Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Lilly Diabetes InternationalLilly Diabetes International
VS
MANKIND PHARMA LTDMANKIND PHARMA LTD
Lilly Diabetes International

Lilly Diabetes International

N/A

Last Update: 19/02/2026

View Profile
Between 750 and 799
https://e.lilly/3Rg4GSW
754/1000Fair

Lilly unites caring with discovery to make life better for people around the world. When you engage with Lilly on LinkedIn (and any other of Lilly’s social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:21
12-month incidents
0
Known data breaches
0
Attack type number
0
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Phase 3, New Delhi, IN

Last Update: 04/04/2026

View Profile
Between 750 and 799
http://www.mankindpharma.com
779/1000Fair

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:17,740
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Lilly Diabetes International

Lilly Diabetes International

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MANKIND PHARMA LTD

MANKIND PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Lilly Diabetes International in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MANKIND PHARMA LTD in 2026.

Incidents

Incident History - Lilly Diabetes International (X = Date, Y = Severity)

Lilly Diabetes International cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MANKIND PHARMA LTD (X = Date, Y = Severity)

MANKIND PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Lilly Diabetes International

Lilly Diabetes International

Incidents
No explicit notable incidents reported.
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Incidents
No explicit notable incidents reported.

FAQ

Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one has the best AI Cybersecurity Score ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents in the past ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents this year ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one has experienced at least one ransomware attack ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one has experienced at least one data breach ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one has experienced at least one targeted cyberattack ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one has experienced at least one vulnerability ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one holds the most compliance certifications ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one holds the fewest compliance certifications ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one has the most subsidiaries ?
Between Lilly Diabetes International company and MANKIND PHARMA LTD company, which one has the largest number of employees ?
Between Lilly Diabetes International and MANKIND PHARMA LTD, which company holds both SOC 2 Type 1 certifications ?
Between Lilly Diabetes International and MANKIND PHARMA LTD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Lilly Diabetes International or MANKIND PHARMA LTD ?
Which company is PCI DSS compliant - Lilly Diabetes International or MANKIND PHARMA LTD ?
Between Lilly Diabetes International and MANKIND PHARMA LTD, which company complies with HIPAA regulations for healthcare data ?
Between Lilly Diabetes International and MANKIND PHARMA LTD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-8325
SUMMARY

A maliciously crafted PDF file, when parsed through Autodesk Revit, can force an Out-of-Bounds Write vulnerability. A malicious actor may leverage this vulnerability to cause a crash, cause data corruption, or execute arbitrary code in the context of the current process.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-7867
SUMMARY

A flaw was found in udisks2. A local attacker with an active console session can exploit insufficient authorization checking on the 'as-user' option in the org.freedesktop.UDisks2.Filesystem.Mount() D-Bus method. This allows the attacker to spoof the 'as-user' parameter, mounting filesystems on behalf of arbitrary users, including privileged accounts. This can lead to local privilege escalation through mount point injection and manipulation of the mount namespace visible to privileged users.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-7406
SUMMARY

A maliciously crafted BMP file, when parsed through certain Autodesk products, can force a Untrusted Pointer Dereference vulnerability. A malicious actor can leverage this vulnerability to execute arbitrary code in the context of the current process.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-7405
SUMMARY

A maliciously crafted TIF file, when parsed through certain Autodesk products during image import, can cause an Out-of-Bounds Read in the image handling library. A malicious actor can leverage this vulnerability to cause a denial of service

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 5.5)
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
1.8
CVE-2026-71555
SUMMARY

PILOS (Platform for Interactive Live-Online Seminars) is a frontend for BigBlueButton. From 2.1.0 until 4.14.1, PILOS does not send a Cross-Origin-Opener-Policy response header, so pages opened by PILOS via a link that opens a new browsing context (e.g., target="_blank") retain a window.opener reference back to the originating PILOS tab. A malicious destination page reached this way can use window.opener to navigate or manipulate the original PILOS tab, a technique known as reverse tabnabbing, potentially redirecting an authenticated user to a phishing page that mimics PILOS. This issue is fixed in version 4.14.1.

PUBLISHED
Date2026-08-06
UPDATED
Date2026-08-06
RISK INFORMATION (Score: 4.1)
CVSS3
Base Score: 4.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.3